Comparisons between Thyroid Hormone Withdrawal and Recombinant Human Thyroid-stimulating Hormone Administration for Radioiodine Ablation in Patients with Intermediate-risk to High-risk Differentiated Thyroid Cancer

被引：0
|
作者：
Iizuka, Y. [1 ]
Katagiri, T. [1 ]
Ogura, K. [1 ]
Inoue, M. [1 ]
Nakamura, K. [1 ]
Mizowaki, T. [1 ]
机构：
[1] Kyoto Univ, Kyoto, Japan
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2019年 / 46卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-359
引用
收藏
页码：S141 / S141
页数：1
相关论文
共 50 条
  • [21] Comparison of salivary gland functions on the salivary gland scan in differentiated thyroid cancer patients underwent radioactive iodine ablation; Recombinant human thyroid-stimulating hormone versus thyroid hormone withdrawal
    Jeong, J.
    Lee, S.
    Ahn, B.
    Lee, J.
    Jeong, S.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S600 - S600
  • [22] Recombinant Human Thyroid Stimulating Hormone-Assisted Radioactive Iodine Remnant Ablation in Thyroid Cancer Patients at Intermediate to High Risk of Recurrence
    Hugo, Jonathan
    Robenshtok, Eyal
    Grewal, Ravinder
    Larson, Steve
    Tuttle, R. Michael
    [J]. THYROID, 2012, 22 (10) : 1007 - 1015
  • [23] Use of recombinant human thyroid-stimulating hormone in the management of well-differentiated thyroid cancer
    Kraenzlin, ME
    Meier, C
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2006, 6 (02) : 167 - 176
  • [24] Economic Evaluation of Recombinant Human Thyroid Stimulating Hormone Stimulation vs. Thyroid Hormone Withdrawal Prior to Radioiodine Ablation for Thyroid Cancer: The Korean Perspective
    Sohn, Seo Young
    Jang, Hye Won
    Cho, Yoon Young
    Kim, Sun Wook
    Chung, Jae Hoon
    [J]. ENDOCRINOLOGY AND METABOLISM, 2015, 30 (04) : 531 - 542
  • [25] High Urinary Iodine, Thyroid Autoantibodies, and Thyroid-Stimulating Hormone for Papillary Thyroid Cancer Risk
    Hengqiang Zhao
    Hehe Li
    Tao Huang
    [J]. Biological Trace Element Research, 2018, 184 : 317 - 324
  • [26] Recombinant human thyrotropin versus thyroid hormone withdrawal in radioiodine remnant ablation for differentiated thyroid cancer: a meta-analysis
    Fu, H.
    Ma, C.
    Tang, L.
    Wu, F.
    Liu, B.
    Wang, H.
    [J]. QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 59 (01): : 121 - 128
  • [27] High Urinary Iodine, Thyroid Autoantibodies, and Thyroid-Stimulating Hormone for Papillary Thyroid Cancer Risk
    Zhao, Hengqiang
    Li, Hehe
    Huang, Tao
    [J]. BIOLOGICAL TRACE ELEMENT RESEARCH, 2018, 184 (02) : 317 - 324
  • [28] Radioiodine thyroid remnant ablation (RRA) in patients with differentiated thyroid cancer (DTC): Impact of recombinant human thyroid-stimulating hormone (rhTSH) on treatment room length-of-stay and utilization
    Antonio Vallejo, Juan
    Mena, Luisa
    Angeles Galvez, Maria
    Marlowe, Robert
    Latre, Jose
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2010, 51
  • [29] Cost-Effectiveness of Using Recombinant Human Thyroid-Stimulating Hormone before Radioiodine Ablation for Thyroid Cancer: The Canadian Perspective
    Mernagh, Paul
    Suebwongpat, Arsupol
    Silverberg, Jay
    Weston, Adele
    [J]. VALUE IN HEALTH, 2010, 13 (02) : 180 - 187
  • [30] Thyroid-Stimulating Hormone, Thyroglobulin, and Thyroid Hormones and Risk of Differentiated Thyroid Carcinoma: The EPIC Study
    Rinaldi, Sabina
    Plummer, Martyn
    Biessy, Carine
    Tsilidis, Konstantinos K.
    Ostergaard, Jane Nautrup
    Overvad, Kim
    Tjonneland, Anne
    Halkjaer, Jytte
    Boutron-Ruault, Marie-Christine
    Clavel-Chapelon, Francoise
    Dossus, Laure
    Kaaks, Rudolf
    Lukanova, Annekatrin
    Boeing, Heiner
    Trichopoulou, Antonia
    Lagiou, Pagona
    Trichopoulos, Dimitrios
    Palli, Domenico
    Agnoli, Claudia
    Tumino, Rosario
    Vineis, Paolo
    Panico, Salvatore
    Bueno-de-Mesquita, H. Bas
    Peeters, Petra H.
    Weiderpass, Elisabete
    Lund, Eiliv
    Quiros, J. Ramon
    Agudo, Antonio
    Molina, Esther
    Larranaga, Nerea
    Navarro, Carmen
    Ardanaz, Eva
    Manjer, Jonas
    Almquist, Martin
    Sandstrom, Maria
    Hennings, Joakim
    Khaw, Kay-Tee
    Schmidt, Julie
    Travis, Ruth C.
    Byrnes, Graham
    Scalbert, Augustin
    Romieu, Isabelle
    Gunter, Marc
    Riboli, Elio
    Franceschi, Silvia
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2014, 106 (06)
12345